Kardigan, Inc.
KARDNasdaqCIK 2123613HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | period not labelled2026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Research and development | $m | not reported | 35.8Research and development, period not labelled, three months to 2025-06-30$35.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 56.4Research and development, Q2 FY2026, three months to 2026-06-30$56.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Operating income | $m | not reported | (57.1)Operating income, period not labelled, three months to 2025-06-30−$57.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | (119)Operating income, Q2 FY2026, three months to 2026-06-30−$118.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Income tax | $m | not reported | 0.0Income tax, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Net income | $m | (18.0)Net income, period not labelled, three months to 2025-03-31−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (57.4)Net income, period not labelled, three months to 2025-06-30−$57.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (56.1)Net income, period not labelled, three months to 2026-03-31−$56.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (116)Net income, Q2 FY2026, three months to 2026-06-30−$116.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Diluted EPS | $ per share | not reported | (4.64)Diluted EPS, period not labelled, three months to 2025-06-30−$4.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | (4.61)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$4.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Basic EPS | $ per share | not reported | (4.64)Basic EPS, period not labelled, three months to 2025-06-30−$4.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | (4.61)Basic EPS, Q2 FY2026, three months to 2026-06-30−$4.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | period not labelled2025-12-31 | period not labelled2026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | not reported | 90.1Cash and equivalents, period not labelled, at 2025-06-30$90.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | 109Cash and equivalents, period not labelled, at 2025-12-31$109.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 384Cash and equivalents, Q2 FY2026, at 2026-06-30$384.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Current assets | $m | not reported | not reported | not reported | 345Current assets, period not labelled, at 2025-12-31$345.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 610Current assets, Q2 FY2026, at 2026-06-30$610.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Total assets | $m | not reported | not reported | not reported | 391Total assets, period not labelled, at 2025-12-31$390.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 722Total assets, Q2 FY2026, at 2026-06-30$721.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | 37.5Current liabilities, period not labelled, at 2025-12-31$37.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 70.0Current liabilities, Q2 FY2026, at 2026-06-30$70.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Total liabilities | $m | not reported | not reported | not reported | 55.1Total liabilities, period not labelled, at 2025-12-31$55.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | not reported | 106Total liabilities, Q2 FY2026, at 2026-06-30$106.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
| Shareholders' equity | $m | (83.2)Shareholders' equity, period not labelled, at 2024-12-31−$83.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (98.3)Shareholders' equity, period not labelled, at 2025-03-31−$98.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (151)Shareholders' equity, period not labelled, at 2025-06-30−$151.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (250)Shareholders' equity, period not labelled, at 2025-12-31−$250.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | (301)Shareholders' equity, period not labelled, at 2026-03-31−$300.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure | 616Shareholders' equity, Q2 FY2026, at 2026-06-30$615.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343418.Report this figure |
Shares
| Line item | Unit | period not labelled2025-06-30 | Q2 FY20262026-06-30 |
|---|---|---|---|
| Diluted shares (weighted) | m shares | 12.4 | 25.2 |
Shares outstanding: 93.50m at Aug 7, 2026, from the cover of the 10-Q filed Aug 11, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.